Cardiovascular Risk Factors

DecentCarbon avatar
DecentCarbon
·
·
Download

Start Quiz

Study Flashcards

24 Questions

What is the result of unchecked compensatory responses in Heart Failure?

Excessive vasoconstriction and volume retention, electrolyte and renal abnormalities

What is the effect of neurohormonal activation on cardiac contractility?

Increase in cardiac contractility

What is the primary role of RAAS and SNS in Heart Failure?

To play a critical role in the development and progression of HF

What is the long-term effect of neurohormonal activation on the heart?

Remodeling of the heart

What is the effect of renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and beta blockers on ventricular and vascular remodeling?

They attenuate or reverse ventricular and vascular remodeling

What is the consequence of baroreceptor dysfunction in Heart Failure?

Excessive vasoconstriction

What is the effect of neurohormonal activation on blood vessels?

Development of atherosclerosis

What is the outcome of landmark trials in Heart Failure that demonstrated the use of RAAS inhibitors and beta blockers?

Reduced morbidity and mortality

What percentage of deaths in the United States list heart failure on the death certificate?

1 in 8

What is the most common cause of death in patients with heart failure?

Progressive heart failure

What percentage of patients with heart failure are hospitalized at least once?

83%

What is the mortality rate at 30 days following an admission for heart failure?

8-14%

What is the risk of death with each subsequent admission for heart failure?

It increases

What is the readmission rate for heart failure at 60 days?

20-25%

What is the significance of guideline-directed therapies in heart failure?

They reduce mortality rates

What is the mortality rate at 5 years following an admission for heart failure?

up to 75%

What is the overall 5­year survival following the diagnosis of HF in primary care?

50%

What is the percentage of patients with HF who are hospitalized at least once after diagnosis?

83%

What is the most common cause of death among patients with HF?

Cardiovascular disease

According to the data, what is the mortality rate at 1 year after an HF admission?

26-37%

What is the percentage of patients who are readmitted with HF within 6 months?

nearly 50%

What is the trend in outcomes for patients with HF in the United States?

Improving

What is the racial disparity in HF outcomes?

Blacks have higher case-fatality rates

What is the percentage of deaths in the United States that list HF on the death certificate?

1 in 8

Study Notes

Heart Failure Epidemiology

  • In the United States, 1 in 8 deaths list heart failure (HF) on the death certificate.
  • The majority of these patients die of cardiovascular causes, most commonly progressive HF or sudden cardiac death.
  • 40% of patients with HF die within 5 years after diagnosis.

Heart Failure Morbidity

  • Hospitalizations are common after an HF diagnosis, with 83% hospitalized at least once.
  • 67%, 54%, and 43% of patients are hospitalized at least two, three, and four times, respectively.
  • Readmission with HF is also common, ranging from 20–25% at 60 days to nearly 50% at 6 months.
  • With each subsequent admission, the risk of death rises.

Predictors of Mortality

  • Clinical and laboratory parameters are independent predictors of mortality, including blood pressure, heart rate, and cardiac contractility.
  • Table 257-1 lists various clinical and laboratory parameters that are independent predictors of mortality.

Neurohormonal Activation

  • Activation of the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS) plays a critical role in the development and progression of HF.
  • Neurohormonal activation leads to increases in heart rate, blood pressure, and cardiac contractility and retention of sodium and water.
  • Over time, these unchecked compensatory responses lead to excessive vasoconstriction and volume retention, electrolyte and renal abnormalities, baroreceptor dysfunction, direct myocardial toxicity, and cardiac arrhythmias.

Landmark Clinical Trials

  • Antagonism of the RAAS and SNS with renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and beta blockers attenuates or reverses ventricular and vascular remodeling and reduces morbidity and mortality.

This quiz assesses your understanding of risk factors contributing to cardiovascular diseases and the use of guideline-directed therapies. It covers statistics and data related to cardiovascular health in the United States.

Make Your Own Quizzes and Flashcards

Convert your notes into interactive study material.

Get started for free

More Quizzes Like This

Atrial Fibrillation Risk Factors Flashcards
5 questions
Coronary Heart Disease and Risk Factors
18 questions
Use Quizgecko on...
Browser
Browser